Researchers at the University of Toronto's Faculty of Applied Science & Engineering have designed a new microfluidic platform ...

Colorectal cancer is now the leading killer for those under 50. Two individuals have shared their experiences with Newsweek.

Novel liquid biopsy tools allowing for diagnosis and prognostic prediction for gastric cancer (GC) patients are urgently ...

It’s the most common type of cancer, affecting one in seven women so it’s understandable that women are asking lots of questions online about whether the shape, size and density of their ...

The treatment was already in Phase III trials, and she provided insights on clinical trial design and quality of life (QoL) measures for patients with EPP. The results from the pivotal trial ...

The treatment was already in Phase III trials, and she provided insights on clinical trial design and quality of life (QoL) measures for patients with EPP. The results from the pivotal trial ...

At the time of her admission, the patient was alert and fully ... Pachter B, Pujol F. Abdominal Tuberculosis or Ovarian Carcinoma: Management Dilemma Associated With an Elevated CA-125 Level.

Early signs of breast cancer are becoming harder to detect because older women are keeping their bust firmer for longer. Because today's postmenopausal women have breast tissue that is young for ...

Its entire footprint is seven times that of the Tom Baker Cancer Centre, whose patient demand outstripped its space within three to four years of its opening in 1981.

Acute salpingitis occurs in 20% to 50% of patients with PID and affects ... Pachter B, Pujol F. Abdominal Tuberculosis or Ovarian Carcinoma: Management Dilemma Associated With an Elevated CA ...

The earliest signs of breast cancer are breast skin changes, size and shape changes, nipple discharge, breast lumps, and breast pain. Abnormal cells will rapidly divide and accumulate, forming a ...

The use of immunotherapy for recurrent nasopharyngeal carcinoma patients is an active area of clinical research. The treatment of head and neck tumors is complex. At Johns Hopkins, our care goes ...